Protara Therapeutics's total assets for Q1 2025 were $168.56M, a decrease of -7.11% from the previous quarter. TARA total liabilities were $10.07M for the fiscal quarter, a -29.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.